Exploring BEATRICE. To explore a different substance…

Names:
BEATRICE · N-Methyl-DOM · N-Me-DOM · 2,5-Dimethoxy-4,N-dimethylamphetamine
IUPAC name:
1-(2,5-Dimethoxy-4-methylphenyl)-N-methylpropan-2-amine
ID: 11 · Formula: C13H21NO2 · Molecular weight: 223.311
InChI: InChI=1S/C13H21NO2/c1-9-6-13(16-5)11(7-10(2)14-3)8-12(9)15-4/h6,8,10,14H,7H2,1-5H3

Schulze-Alexandru, M; Kovar, K; Vedani, A. Quasi-atomistic receptor surrogates for the 5-HT2A receptor: A 3D-QSAR study on hallucinogenic substances. Quant. Struct.-Act. Relat., 1 Dec 1999, 18 (6), 548–560. 312 kB. http://dx.doi.org/10.1002/(SICI)1521-3838(199912)18:6<548::AID-QSAR548>3.0.CO;2-B

Ger, A; Ger, D. Triple Goddess of the Night. Br. Neurosci. Assoc. Bull., 1 Mar 2011, 63, 28–30. 234 kB. Dmitri Ger is credited with the discovery of Jelena, also known as 2C-IP.

Ho, B; Tansey, LW; Balster, RL; An, R; McIsaac, WM; Harris, RT. Amphetamine analogs. II. Methylated phenethylamines. J. Med. Chem., 1 Jan 1970, 13 (1), 134–135. 278 kB. http://dx.doi.org/10.1021/jm00295a034

Glennon, RA; Titeler, M; McKenney, JD. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci., 17 Dec 1984, 35 (25), 2505–2511. 332 kB. http://dx.doi.org/10.1016/0024-3205(84)90436-3

Shannon, M; Battaglia, G; Glennon, RA; Titeler, M. 5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA). Eur. J. Pharmacol., 15 Jun 1984, 102 (1), 23–29. 461 kB. http://dx.doi.org/10.1016/0014-2999(84)90333-9

Glennon, RA; Young, R; Jacyno, JM. Indolealkylamine and phenalkylamine hallucinogens: Effect of α-methyl and N-methyl substituents on behavioral activity. Biochem. Pharmacol., 1 Apr 1983, 32 (7), 1267–1273. 591 kB. http://dx.doi.org/10.1016/0006-2952(83)90281-2

Halberstadt, AL. Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens. In Current Topics in Behavioral Neurosciences; , 2016; pp 1–29. 826 kB. http://dx.doi.org/10.1007/7854_2016_64

DOM
N-cPr-DOM
N-HO-DOM
N,N-Me-DOM
N-Et-DOM
N-cPM-DOM
N-Me-2C-D
2,5-DMMA · METHYL-DMA
N-Me-DOB · METHYL-DOB
2,5-IDNA
N-Me-TMA-2 · METHYL-TMA-2
N-Me-ALEPH
N-Me-ALEPH-2
N-Me-ALEPH-7
4,N-Me-2-MA
DMCPA
α-CP-2C-D
DOMAI · DOM-AI
DOMAT · DOM-AT
homo-DOM
DMMCPA
HO-DOMAI
DMMCPA
DMCBA
ARIADNE
2C-P
DOET
GANESHA
IRIS
JUNO
N,N-Me-2C-D
2C-D-2,5-DIEtO · 2CD-2,5-DIETO
2CE-5ETO
2,5-DNNA
2,6-DNNA
3,5-DNNA
α-Me-DOM · CHARMIAN
DAPHNE
ELVIRA
FLORENCE
2,4-DNNA
2155
25H-NPro
2C-IP
4,2,6-DOET · ψ-DOET
4-Butoxynorephedrine
homo-N,N-Me-2,5-DMPEA
homo-DOM
BO3MIP
β-HO-N-Pr-PMA
4C-2,3-DMPEA
N,N-Me-2,3-EMPEA
N,N-Me-DMA
6622
N,N-Me-3,4-EMPEA
N,N-Me-4,3-EMPEA
N-Me-DEPEA
DEA
β,N,N-Me-2,5-DMPEA
4,2,3-DOET
3,2,4-DOET
2,3,4-DOET
5,2,3-DOET
3,2,5-DOET
2,3,5-DOET
5,2,4-DOET
β,β-Me-2C-D
β-Me-DOM
2,4,5-DOET
4,3,5-DOET
3,4,5-DOET
6,2,3-DOET
3,2,6-DOET
2,3,6-DOET
2,4,6-DOET
4-Me-2,6-MEA
6-Me-2,4-DEPEA
2C-G-21
2C-G-12
3,4,6-Me-2,5-DMPEA
IPOMA
POMA
DOM
N-cPr-DOM
N-HO-DOM
N,N-Me-DOM
N-Et-DOM
N-cPM-DOM
N-Me-2C-D
2,5-DMMA · METHYL-DMA
N-Me-DOB · METHYL-DOB
2,5-IDNA
N-Me-TMA-2 · METHYL-TMA-2
N-Me-ALEPH
N-Me-ALEPH-2
N-Me-ALEPH-7
4,N-Me-2-MA
DMCPA
α-CP-2C-D
DOMAI · DOM-AI
DOMAT · DOM-AT
homo-DOM
DMMCPA
HO-DOMAI
DMMCPA
DMCBA
ARIADNE
2C-P
DOET
GANESHA
IRIS
JUNO
N,N-Me-2C-D
2C-D-2,5-DIEtO · 2CD-2,5-DIETO
2CE-5ETO
2,5-DNNA
2,6-DNNA
3,5-DNNA
α-Me-DOM · CHARMIAN
DAPHNE
ELVIRA
FLORENCE
2,4-DNNA
2155
25H-NPro
2C-IP
4,2,6-DOET · ψ-DOET
4-Butoxynorephedrine
homo-N,N-Me-2,5-DMPEA
homo-DOM
BO3MIP
β-HO-N-Pr-PMA
4C-2,3-DMPEA
N,N-Me-2,3-EMPEA
N,N-Me-DMA
6622
N,N-Me-3,4-EMPEA
N,N-Me-4,3-EMPEA
N-Me-DEPEA
DEA
β,N,N-Me-2,5-DMPEA
4,2,3-DOET
3,2,4-DOET
2,3,4-DOET
5,2,3-DOET
3,2,5-DOET
2,3,5-DOET
5,2,4-DOET
β,β-Me-2C-D
β-Me-DOM
2,4,5-DOET
4,3,5-DOET
3,4,5-DOET
6,2,3-DOET
3,2,6-DOET
2,3,6-DOET
2,4,6-DOET
4-Me-2,6-MEA
6-Me-2,4-DEPEA
2C-G-21
2C-G-12
3,4,6-Me-2,5-DMPEA
IPOMA
POMA
19 November 2017 · Creative Commons BY-NC-SA ·